Fundraising Fox

Slate Bio

Charlottesville, US · Delaware corporation · 2 known investors

slatebio.com ↗

Slate Bio develops regulatory T cell (Treg) therapies for treating autoimmune diseases. The company focuses on advancing immunology treatments for patients with autoimmune conditions.

BiotechDigital HealthMedical Devices

Founders & leadership

RC
Robert CreedenDirector
KW
Kurt WoerpelExecutive Officer
KS
Kyparissia SirinakisDirector
AJ
Andrew J KrouseExecutive Officer, Director

Investors · 2

Epidarex CapitalBethesda · $2.5M – $6.3Mvia Kyparissia Sirinakis · board
VTC VenturesRoanoke · $100K – $5M

Reported raises · per SEC filings

Form D private placements
▶$2.8MraisedMay 2023 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew KrouseExecutive Officer, Director
  • Kurt WoerpelExecutive Officer
  • Robert CreedenDirector
  • Kyparissia SirinakisDirector
  • Brian GallagherDirector
Offering amount
$3M
Amount sold
$2.8M
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJun 2021 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert CreedenDirector
  • Kurt WoerpelExecutive Officer
  • Kyparissia SirinakisDirector
  • Andrew J KrouseExecutive Officer, Director
Offering amount
$2M
Amount sold
$2M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.